BALDACCI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 6.272
EU - Europa 3.029
AS - Asia 679
AF - Africa 181
OC - Oceania 12
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.179
Nazione #
US - Stati Uniti d'America 6.153
IT - Italia 1.328
SE - Svezia 594
CN - Cina 344
DE - Germania 282
BG - Bulgaria 266
AT - Austria 145
SG - Singapore 127
GB - Regno Unito 118
CA - Canada 114
CI - Costa d'Avorio 105
VN - Vietnam 98
FI - Finlandia 61
SN - Senegal 47
FR - Francia 44
RU - Federazione Russa 39
HK - Hong Kong 35
UA - Ucraina 35
BE - Belgio 30
TR - Turchia 28
NG - Nigeria 27
PL - Polonia 25
IN - India 19
CH - Svizzera 17
GR - Grecia 12
AU - Australia 9
TW - Taiwan 9
NL - Olanda 7
CZ - Repubblica Ceca 6
KR - Corea 6
ES - Italia 5
RO - Romania 4
BR - Brasile 3
IE - Irlanda 3
IR - Iran 3
MX - Messico 3
NZ - Nuova Zelanda 3
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IM - Isola di Man 1
JP - Giappone 1
LU - Lussemburgo 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 10.179
Città #
Woodbridge 881
Fairfield 871
Chandler 533
Ann Arbor 504
Serra 501
Houston 439
Ashburn 412
Seattle 365
Wilmington 299
Cambridge 291
Sofia 266
New York 201
Milan 169
Beijing 156
Vienna 139
Princeton 125
Ottawa 109
Lawrence 107
Abidjan 105
Florence 102
Medford 91
Pisa 84
Des Moines 74
Frankfurt am Main 68
Nanjing 50
San Diego 49
Dakar 47
Jacksonville 47
Rome 46
Dearborn 43
Bremen 42
Dong Ket 39
Boulder 31
Hong Kong 31
Brussels 28
London 28
Lagos 27
Norwalk 26
Izmir 24
Redwood City 23
Warsaw 23
Washington 23
Nanchang 21
Lucca 19
Lancaster 18
Shenyang 18
Los Angeles 16
Bern 15
Fort Worth 15
Kunming 15
Hebei 14
Vicopisano 14
Nürnberg 12
Cascina 11
Paris 10
Bologna 9
Calci 9
Jüchen 9
Livorno 9
Auburn Hills 8
Hefei 8
Pune 8
San Giuliano Terme 8
Jiaxing 7
Marseille 7
San Francisco 7
Boardman 6
College Station 6
Guangzhou 6
La Spezia 6
Seelze 6
Bergamo 5
Kaohsiung City 5
Santa Maria a Monte 5
Shenzhen 5
Tappahannock 5
Changsha 4
Hangzhou 4
Jinan 4
Ogden 4
Tianjin 4
Viareggio 4
Wandsworth 4
Adelaide 3
Auckland 3
Capannori 3
Chehalis 3
Durham 3
East Lansing 3
Genoa 3
Genova 3
Kilburn 3
Lansing 3
Lappeenranta 3
Marina Di Carrara 3
Melbourne 3
Munich 3
Pavia 3
Phoenix 3
Redmond 3
Totale 7.940
Nome #
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 240
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 213
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 184
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 174
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 172
Spontaneous bilateral carotid artery dissection and hereditary haemochromatosis: what relationship? 171
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 165
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 146
Sexual headache: two familiar orgasmic headache cases and review of the literature. 145
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 143
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 141
Recanalization and pseudoaneurism during spontaneous cervical artery dissection follow-up 138
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 138
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 136
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 134
SUNA syndrome with seasonal pattern 127
Vertebrobasilar recording with contrast transcranial Doppler in right-to-left shunt diagnosis 127
Nummular headache dramatically responsive to indomethacin 126
Postpartum headache due to spontaneous cervical artery dissection 126
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 125
null 125
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 124
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 123
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 121
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 117
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 117
Prevalence of right-to-left shunt in patients with cluster headache 115
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 113
Localized calcific hematoma of the scalp presenting as a nummular-like headache: a case report. 111
Migraine features in migraineurs with and without anxiety-depression symptoms: A hospital-based study 110
Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients 109
Biomarker-guided classification scheme of neurodegenerative diseases 109
null 108
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40 105
Triggers in allodynic and non-allodynic migraineurs. A clinic setting study. 102
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 102
Reliability of administrative data for the identification of Parkinson's disease cohorts. 102
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases 101
Clinical features associated with ictal osmophobia in migraine. 99
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 99
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 98
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 97
Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes 96
Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. 94
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 94
A case of idiopathic low CSF pressure headache presenting as cough headache. 93
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 93
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 92
null 91
Cognitive correlates of negative symptoms in behavioral variant frontotemporal dementia: implications for the frontal lobe syndrome. 91
'Airlplane headache' with aura 90
Spontaneous Dorsal Extramedullary Hematoma: A Rare Case Presenting as Isolated Thunderclap Headache 90
Cerebrospinal fluid neurogranin as a biomarker of neurodegenerative diseases: A cross-sectional study 89
null 86
Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging study. 86
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease 86
Paroxysmal exertion-induced dystonia secondary to Erdheim-Chester disease. 86
"INDOTEST" in atypical hemicrania continua 85
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 85
Bilateral thalamic infarct caused by spontaneous vertebral artery dissection in pre-eclampsia with HELLP syndrome: a previously unreported association. 84
Biomarker-guided clustering of Alzheimer's disease clinical syndromes 84
Progressive impairment of decision-making in behavioral-variant frontotemporal dementia. 83
Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology 83
null 81
Peri-ictal prolonged atrial fibrillation after generalized seizures: description of a case and etiopathological considerations. 80
How aware are migraineurs of their triggers? 79
Levodopa response in dementia with lewy bodies: a 1-year follow-up study. 78
Head tremor as a warning symptom of rapidly progressive syringomyelia: a case report 78
Concomitant development of hypersexuality and delusional jealousy in patients with Parkinson's disease: A case series. 77
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 75
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 75
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 75
The "closing-in" phenomenon in Parkinson's disease dementia and lewy-body dementia. 73
Decreased and increased cortical activation coexist in de novo Parkinson's disease. 71
Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases 71
Impact of COVID-19 pandemic on cognition in Parkinson's disease 70
Plasma levels of oxidative stress markers, before and after BoNT/A Treatment, in chronic migraine 70
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease 69
Decision-making impairment in a patient with new concomitant diagnoses of Parkinson's disease and HIV. 69
Precision pharmacology for Alzheimer's disease 68
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 66
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 64
fMRI changes in cortical activation during task performance with the unaffected hand partially reverse after ropinirole treatment in de novo Parkinson's disease. 63
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases 62
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease 60
Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum 55
Gray matter network disruptions and regional amyloid beta in cognitively normal adults 55
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints 55
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 55
Donepezil improves vascular function in a mouse model of Alzheimer's disease 54
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 53
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence 50
null 48
Inflammation and neurodegeneration plasmatic biomarkers in patients with obstructive sleep apnea syndrome and mild cognitive impairment 47
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 45
Hypoactivation of the primary sensorimotor cortex in de novo Parkinson's disease : a motor fMRI study under controlled conditions. 44
Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach 43
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 43
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases 43
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 41
Totale 9.644
Categoria #
all - tutte 29.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019520 0 0 0 0 0 0 0 0 0 0 287 233
2019/20202.394 209 175 384 132 185 292 275 193 242 128 134 45
2020/20211.027 72 96 41 52 168 40 52 85 123 110 68 120
2021/20221.245 17 42 34 70 257 145 38 81 78 41 107 335
2022/20232.052 208 275 177 159 200 233 19 144 409 13 155 60
2023/20241.168 127 133 175 101 188 254 95 47 14 32 2 0
Totale 10.437